Fatemeh Rangani

Alla övriga publikationer

Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):867
Effect of Ocrelizumab on regulation of IL2 pathway in Multiple Sclerosis patients
Rangani F; Nahayati MA; Alimardani M; Bakhtiari SHA; Kakhki MP
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):865-866
The association between IL2RA risk SNPs and Multiple Sclerosis susceptibility in Iranian eastern population
Rangani F; Rakhshi N; Heidari H; Mezerji ZK; Alikhah A; Dehghanzad R; Abbasi B; Ahmadi A; Nikravesh A; Kakhki MP

Small non-coding RNAs as novel biomarkers for precision medicine in Multiple Sclerosis
Neuroförbundet
12 December 2024 - 12 December 2026